Hydrogen
peroxide bio-decontamination technology was one of the hot topics at this year's
49th Annual Meeting of the Infectious Diseases Society of America and the HIV
Medicine Association. Three scientific abstracts were presented on
hydrogen peroxide vapour (HPV) at the meeting in Boston, Massachusetts on
October 20-23.
Commenting on this latest research, James
Salkeld Head of Healthcare at Bioquell said, "Hydrogen peroxide vapour
technology continues to have a strong profile among infection control
professionals at all levels. Its efficacy at dealing with key healthcare
associated infections (HCAIs) such as
Clostridium difficile and
Acinetobacter
is becoming better known, providing a rapid solution to help in bringing
outbreaks under control and reducing endemic infection."
The abstracts included reports of reducing
endemic cases of
Clostridium difficile and controlling outbreaks of
Acinetobacter
baumannii and NDM-1-producing
Klebsiella pneumoniae.
Performed at the Wellstar group of
hospitals in Atlanta, GA, the first study illustrates a system-wide reduction
in the incidence of
C. difficile, VRE and MRSA following the
introduction of a bundle of prevention and control measures including Bioquell's
HPV proactive service (onsite equipment and bio-decontamination specialists).
Here
C. difficile rates fell by 36%, VRE by 68% and MRSA by 11%.
Management of a multi-year outbreak of
Acinetobacter
baumannii in an ICU setting was highlighted in the second study at Albany,
NY. With the introduction of Bioquell HPV technology in 2010, rates dropped by
80% against baseline and 95% compared to the peak of the outbreak. Prior to the
HPV technology, standard infection control methods had failed to bring the outbreaks
under control. Whilst the introduction of surveillance cultures made some
impact, implementation of HPV technology solved the problem.
The third study was conducted at a Howard
County Hospital, affiliated with Johns Hopkins, MD. Although NDM-1-producing
Klebsiella pneumoniae was not found in the environment during the study,
the team decided to use Bioquell HPV technology to disinfect the patient care
area. Such treatment is vital when dealing with some of the hard to treat
Gram-negatives.
The three abstracts are titled:-
A System-Wide
Reduction in the Incidence of C. difficile and MDROs due to an Infection
Prevention & Control Bundle
- Management of a
multi-year MDR Acinetobacter baumannii outbreak in the ICU setting
- Management of a New
Delhi Metallo-beta-lactamase-1 enzyme (NDM-1)-Producing Klebsiella
pneumoniae : Infection Control and Medical Implications
For further information visit www.bioquell.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.